Bubble Robotics | $5,000,000 | (Apr 23, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)
Mosaic(US) | $18,000,000 | (Apr 23, 2026)
Certified by Founder
Lodge
Ochre Bio
start up
United Kingdom
- Oxford
- 11/10/2022
- Series A
- $30,000,000
Ochre Bio develops RNA therapies for chronic liver diseases, a leading cause of death globally.
Privately held, Ochre Bio is situated within the heart of Oxford’s biotech innovation hub. To learn more, please visit www.ochre-bio.com.
- Industry Biotechnology Research
- Website https://www.ochre-bio.com/
- LinkedIn https://www.linkedin.com/company/ochre-bio/
Related People
Jack O'MearaCo Founder
United Kingdom -
Oxford, England,
I help to get new medicines and healthcare technologies to patients.
Interested in the intersection of science, medicine, and business.
Omeza | $8,500,000 | (Apr 23, 2026)
Calibre | $3,300,000 | (Apr 23, 2026)
Nox Mobility | $2,341,030 | (Apr 23, 2026)
BuildForever | $9,500,000 | (Apr 23, 2026)
10x Science (YC W26) | $4,800,000 | (Apr 23, 2026)
Schematic | $6,500,000 | (Apr 23, 2026)
Crewline | $7,100,000 | (Apr 23, 2026)
Monk | $25,000,000 | (Apr 22, 2026)
NeoCognition | $40,000,000 | (Apr 22, 2026)